Future Opportunities in Malaria Management Offered by Probiotics


Cite item

Full Text

About the authors

Amandeep Singh

Department of Pharmaceutics, ISF College of Pharmacy

Author for correspondence.
Email: info@benthamscience.net

Rohit Bhatia

Department of Pharmaceutical Chemistry, ISF College of Pharmacy

Email: info@benthamscience.net

References

  1. Deng SQ, Cai Y, Wang DQ. Editorial: Novel strategies for controlling mosquito-borne diseases. Front Public Health 2023; 11: 1171634. doi: 10.3389/fpubh.2023.1171634 PMID: 36992881
  2. Kogan F, Kogan F. Malaria Burden. Springer 2020. doi: 10.1007/978-3-030-46020-4_2
  3. Balikagala B, Fukuda N, Ikeda M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med 2021; 385(13): 1163-71. doi: 10.1056/NEJMoa2101746 PMID: 34551228
  4. Al-Awadhi M, Ahmad S, Iqbal J. Current status and the epidemiology of malaria in the Middle East Region and beyond. Microorganisms 2021; 9(2): 338. doi: 10.3390/microorganisms9020338 PMID: 33572053
  5. Tachibana M, Takashima E, Morita M, et al. Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation. Parasitol Int 2022; 87: 102525. doi: 10.1016/j.parint.2021.102525 PMID: 34896614
  6. Etefia E, Etoh PI. Malaria vaccine development: Challenges and prospects. Med Pharmac J 2023; 2(1): 28-42. doi: 10.55940/medphar202225
  7. Khan N, Awasthi G, Das A. How can the complex epidemiology of malaria in India impact its elimination? Trends Parasitol 2023; 39(6): 432-44. doi: 10.1016/j.pt.2023.03.006 PMID: 37031071
  8. Legesse Y, Tegegn A, Belachew T, Tushune K. Knowledge, attitude and practice about malaria transmission and its preventive measures among households in urban areas of Assosa Zone, Western Ethiopia. Ethiop J Health Dev 2007; 21(2): 157-65. doi: 10.4314/ejhd.v21i2.10044
  9. Siddiqui AJ, Bhardwaj J, Saxena J, et al. A critical review on human malaria and schistosomiasis vaccines: Current state, recent advancements, and developments. Vaccines 2023; 11(4): 792. doi: 10.3390/vaccines11040792 PMID: 37112704
  10. Fitri LE, Sardjono TW, Winaris N, et al. Bifidobacterium longum administration diminishes parasitemia and inflammation during Plasmodium berghei infection in mice. J Inflamm Res 2023; 16: 1393-404. doi: 10.2147/JIR.S400782 PMID: 37006809
  11. Toukam LL, Tatsinkou Fossi B, Taiwe GS, et al. In vivo antimalarial activity of a probiotic bacterium Lactobacillus sakei isolated from traditionally fermented milk in BALB/c mice infected with Plasmodium berghei ANKA. J Ethnopharmacol 2021; 280: 114448. doi: 10.1016/j.jep.2021.114448 PMID: 34303805
  12. Mahajan E, Sinha S, Bhatia A, Sehgal R, Medhi B. Evaluation of the effect of probiotic as add-on therapy with conventional therapy and alone in malaria induced mice. BMC Res Notes 2021; 14(1): 246. doi: 10.1186/s13104-021-05661-1 PMID: 34193269
  13. Gut AM, Vasiljevic T, Yeager T, Donkor ON. Salmonella infection: Prevention and treatment by antibiotics and probiotic yeasts: a review. Microbiology 2018; 164(11): 1327-44. doi: 10.1099/mic.0.000709 PMID: 30136920
  14. Oh B, Kim BS, Kim JW, et al. The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial. Helicobacter 2016; 21(3): 165-74. doi: 10.1111/hel.12270 PMID: 26395781
  15. Xavier-Santos D, Padilha M, Fabiano GA, et al. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci Technol 2022; 120: 174-92. doi: 10.1016/j.tifs.2021.12.033 PMID: 35002079

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers